Hopkins NK et al. |
Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer. |
1984 |
Biochim. Biophys. Acta |
pmid:6089913
|
Emilsson A and Sundler R |
Differential activation of phosphatidylinositol deacylation and a pathway via diphosphoinositide in macrophages responding to zymosan and ionophore A23187. |
1984 |
J. Biol. Chem. |
pmid:6321496
|
Hillmar I et al. |
Effects of a thio analog of platelet-activating factor on platelet aggregation and adenosine 3',5'-monophosphate concentration in hepatocyte suspensions and in platelets. A comparison with the naturally occurring compound. |
1984 |
Hoppe-Seyler's Z. Physiol. Chem. |
pmid:6325321
|
Krishnamurthi S et al. |
Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. |
1984 |
Biochem. Pharmacol. |
pmid:6091666
|
Kamitani T et al. |
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine. |
1984 |
Eur. J. Pharmacol. |
pmid:6144557
|
Tokumura A et al. |
Contractile effect of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine on strips of isolated rat intestine. |
1984 |
J. Pharm. Pharmacol. |
pmid:6144763
|
Pirotzky E et al. |
Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys. |
1984 |
Kidney Int. |
pmid:6144811
|
Gómez-Cambronero J et al. |
The role of calcium ions in the process of acetyltransferase activation during the formation of platelet-activating factor (PAF-acether). |
1984 |
Biochem. J. |
pmid:6146309
|
Rao AK et al. |
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. |
1984 |
Am. J. Hematol. |
pmid:6431801
|
Colditz IG and Movat HZ |
Desensitization of acute inflammatory lesions to chemotaxins and endotoxin. |
1984 |
J. Immunol. |
pmid:6088633
|
Siess W et al. |
Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. |
1984 |
J. Biol. Chem. |
pmid:6429141
|
Knauer KA et al. |
Platelet augmentation of IgE-dependent histamine release from human basophils and mast cells. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6200443
|
Kazimierczak W et al. |
Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step. |
1984 |
Am. Rev. Respir. Dis. |
pmid:6201094
|
Malpass TW et al. |
The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass. |
1984 |
J. Thorac. Cardiovasc. Surg. |
pmid:6231433
|
Goldenberg MM and Meurer RD |
A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat. |
1984 |
Prostaglandins |
pmid:6505225
|
Wissner A et al. |
Analogues of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain. |
1984 |
J. Med. Chem. |
pmid:6471071
|
Mallet AI et al. |
Rapid isocratic high-performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin. |
1984 |
J. Chromatogr. |
pmid:6480761
|
Kenzora JL et al. |
Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. |
1984 |
J. Clin. Invest. |
pmid:6480824
|
Jackson EM et al. |
High performance liquid chromatography of platelet-activating factors. |
1984 |
J. Lipid Res. |
pmid:6481248
|
Dewar A et al. |
Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. |
1984 |
J. Pathol. |
pmid:6481526
|
Goldstein BM et al. |
Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat. |
1984 |
Life Sci. |
pmid:6482659
|
Baldo BA and Tovey ER |
Allergy, allergens and allergen standardization. |
1984 |
Med. J. Aust. |
pmid:6482786
|
Chilton FH et al. |
1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. |
1984 |
J. Biol. Chem. |
pmid:6434535
|
Caramelo C et al. |
Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6732788
|
Lenihan DJ and Lee TC |
Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6732789
|
Kasuya Y et al. |
Hypotensive actions of some analogues of platelet-activating factor (PAF) with higher potencies than natural PAF. |
1984 |
Can. J. Physiol. Pharmacol. |
pmid:6733593
|
Page CP et al. |
Platelets and bronchospasm. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6735490
|
Jouvin-Marche E et al. |
Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. |
1984 |
J. Immunol. |
pmid:6736649
|
Ostermann G et al. |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. |
1984 |
Thromb. Res. |
pmid:6710440
|
Levi R et al. |
Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. |
1984 |
Circ. Res. |
pmid:6692502
|
Humphrey DM et al. |
Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. |
1984 |
Lab. Invest. |
pmid:6694349
|
Masugi F et al. |
Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat. |
1984 |
Life Sci. |
pmid:6694519
|
Bottecchia D et al. |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. |
1984 |
Scand J Haematol |
pmid:6695148
|
Blank ML et al. |
A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6696762
|
Masugi F et al. |
[Etiological studies of hypertension. G. APRL (antihypertensive polar renomedullary lipid)]. |
1984 |
Nippon Rinsho |
pmid:6716685
|
Kester M et al. |
The potentiation of arterial contraction with platelet activating factor. |
1984 |
Pflugers Arch. |
pmid:6718228
|
Pelczar-Wissner CJ et al. |
Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect. |
1984 |
Am. J. Hematol. |
pmid:6720685
|
Guay DR and Richard A |
Heparin-induced thrombocytopenia--association with a platelet aggregating factor and cross-sensitivity to bovine and porcine heparin. |
1984 |
Drug Intell Clin Pharm |
pmid:6723517
|
Poitevin B et al. |
Paf-acether generates chemiluminescence in human neutrophils in the absence of cytochalasin B. |
1984 |
Immunopharmacology |
pmid:6724877
|
Kawaguchi H and Yasuda H |
Platelet-activating factor stimulates phospholipase in quiescent Swiss mouse 3T3 fibroblast. |
1984 |
FEBS Lett. |
pmid:6436057
|
Kasuya Y et al. |
Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF). |
1984 |
J. Pharmacobio-dyn. |
pmid:6726619
|
McGivern DV and Basran GS |
Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man. |
1984 |
Eur. J. Pharmacol. |
pmid:6592097
|
Beaubien BB et al. |
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6594998
|
Roubin R et al. |
The role of immunomodulators in the production of lipid mediators by macrophages (M phi). |
1984 |
Int J Tissue React |
pmid:6596298
|
Schleimer RP et al. |
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. |
1984 |
J. Allergy Clin. Immunol. |
pmid:6208229
|
Nishihira J et al. |
Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid during labor. |
1984 |
Lipids |
pmid:6527609
|
Lefer AM et al. |
Pathophysiological mechanisms of sudden death induced by platelet activating factor. |
1984 |
Br. J. Pharmacol. |
pmid:6435705
|
Gunby P |
A new piece for the puzzle of inflammation. |
1984 |
JAMA |
pmid:6420583
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|
Billah MM and Siegel MI |
Calmodulin antagonists inhibit formation of platelet-activating factor in stimulated human neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6422930
|